Alkem Laboratories Limited — Board Meeting, 14-08-2026: Outcome of Board Meeting
14-08-2026 | 01:45 pm
14-08-2026 | 01:45 pm
Alkem Laboratories' board approved Q1FY27 consolidated financial results. Revenue from operations hit ₹3,740.15 Cr, with net profit at ₹519.96 Cr (EPS ₹43.49). Post-quarter, the company acquired a majority stake in Occlutech Holding AG, Switzerland.
No comments yet. Be the first to comment!
